CN Patent

CN104853744B — 气溶胶化伊洛前列素的给药

Assigned to Vectura GmbH · Expires 2018-01-19 · 8y expired

What this patent protects

本发明涉及可用于治疗肺部疾病如肺动脉高血压的新方法、组合物和试剂盒。具体而言，本发明提供了用于吸入疗法的伊洛前列素的可气溶胶化组合物。其通过在短时间内吸入给药，其对患者友善、有效且为良好耐受的。吸入法可例如使用基于振动网格技术的有效喷雾器来完成。

USPTO Abstract

本发明涉及可用于治疗肺部疾病如肺动脉高血压的新方法、组合物和试剂盒。具体而言，本发明提供了用于吸入疗法的伊洛前列素的可气溶胶化组合物。其通过在短时间内吸入给药，其对患者友善、有效且为良好耐受的。吸入法可例如使用基于振动网格技术的有效喷雾器来完成。

Drugs covered by this patent

Patent Metadata

Patent number
CN104853744B
Jurisdiction
CN
Classification
—
Expires
2018-01-19
Drug substance claim
No
Drug product claim
No
Assignee
Vectura GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.